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Abstract

Ischemic Preconditioning Protects Adult Rat Cardiomyocytes Against Necrosis but
not Apoptosis, via Activation of PKG
By Marc Caligtan, B.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science in Physiology at Virginia Commonwealth University.

Virginia Commonwealth University, 2005

Major Director: Rakesh C. Kukreja, Ph.D
Professor of Internal Medicine, Physiology and Emergency Medicine

The role of cyclic guanosine monophosphate (cGMP) dependent protein kinase
(PKG) in necrotic and apoptotic pathways of many cell types is well established;
however its role in the ischemic preconditioning (IPC) of cardiomyocytes is not clearly
defined. In the current study, we assessed the hypothesis that PKG protects against cell
death following ischemidreperfusion injury in myocytes subjected to IPC.
Freshly isolated adult rat ventricular myocytes were subjected to IPC by
incubating in ischemic buffer for 30 minutes (min) followed by incubation in normal
medium for 30 min. Prolonged simulated ischemia (SI) was created by incubating
myocytes in the ischemic buffer for 90 min and reoxygenation (RO) for 120 min in the
normal medium. Necrosis was determined by trypan blue exclusion and apoptosis was
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assessed by TUNEL assay. IPC reduced necrosis as shown by significant decrease in
trypan blue positive cells as compared to virgin non-preconditioned myocytes subjected
to SI and RO alone (p<.01). Similarly, the number of TUNEL positive myocytes
following SI and 18 hrs of RO were significantly reduced in the IPC group. Treatment
with PKG inhibitor, KT5832 (2pM) completely abolished the protection against necrosis
by IPC.

However, KT5832 failed to abolish the protective affect of IPC against

apoptosis. Furthermore, myocytes infected with an adenoviral construct of PKG-la

o4 particles/cell)

( 1x 1

significantly reduced the number of trypan blue and TUNEL

positive cells. These results suggest that the PKG signaling pathway plays an essential
role in the preconditioning of myocytes against necrosis following SI / RO injury.
Furthermore, while the overexpression of PKG protects myocytes against necrosis, as
well as apoptosis, IPC may not induce a sufficient level of PKG during 18 hours of RO to
induce protection against apoptosis.

CHAPTER 1
Introduction
According to the American Heart Association in 2002, 38% of all deaths in the
United States were caused by Coronary Heart Disease (CHD) and 7.1 million Americans
suffered myocardial infarction (MI). It is therefore important to find effective forms of
prevention or treatment for such a common disease. While many patients may benefit
from conventional pharmaceuticals and life style modifications others need an alternative
means of treatment.

One possibility that remains is the preconditioning of the

myocardium in order to prevent cellular death as a result of MI.
Ischemic preconditioning (IPC) is the phenomenon whereby a sublethal period of
ischemia and reperfusion initiate a cascade of events that eventually protects the heart
against further ischemic injury. This was first demonstrated by Murry et al., 1986. Their
study showed that a series of shorter circumflex occlusions and reperfusions
preconditioned the canine heart against a subsequent longer period of ischemia. The
preconditioned group demonstrated a 75% smaller infarct size than the control group
subjected to the longer period of ischemia alone (22).
The immediate protection conferred by IPC is now commonly referred to as the
classic or early form and lasts between 1-4 hrs (8, 23). Other studies have shown that
protection returns within 24h after IPC and is referred to as the second window (SWOP)

or the late phase of preconditioning (21).
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The SWOP is longer but the fortification

against cell death is less pronounced than its classical counterpart. Since 1986, research
in the field of P C has focused on its underlying mechanisms which are quite complex
and may involve several parallel pathways.

Research has also shown that several

pharmacological agents such as sidenafil (Viagra), acetylcholine, and bradykinin mimic
P C (26, 28, 48). The mechanism of P C involves the up regulation of nitric oxide
synthase (NOS) which consequently increases the production of NO (Fig. I).
Subsequently, NO activates guanylyl cyclase which increases the conversion of guanylyl
triphophate (GTP) into cGMP. Increased levels of cGMP further activate PKG, which
may phosphorylate KATPchannels resulting in cardioprotection. The purpose of this study
was to specifically identify the role of PKG in the protection against necrosis and
apoptosis following P C and to test whether the overexpression of PKG induces tolerance
against SI and reoxygenation (RO).
In the literature, the process of P C has been divided into three specific
components; triggers, mediators, and effectors. The distinction among all three elements
is temporal and relative to the final period of ischemia (Fig. 2). The trigger is the initiator
of molecular signaling that responds to the first bout of ischemia.

Mediators are

molecular signaling events that occur during and after the longer bout of ischemia. Lastly,
effectors are the signaling events that directly cause protection against cell death.
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Figure 1: Proposed mechanism of ischemic and pharmacological preconditioning
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Figure 2: Temporal Representation of Triggers, Mediators and End Effectors
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Signaling Cascade
Ischemia causes physiologic changes within the heart including the release of
adenosine, bradykinin, norepinephrine, and opioids. Attachment of these endogenous
molecules to their respective cell surface receptors initiates the P C response. Other
triggering substances include NO and ROS.

Nitric Oxide 1 Nitric Oxide Synthase
NO is an endogenous molecule that regulates vascular tone, heart rate, and
contractility. It is produced by the conversion of L-arginine to citrulline by the enzyme
nitric oxide synthase (NOS). There are three types of NOS isozymes that originate in the
heart; endothelial NOS (eNOS), inducible NOS (iNOS), and neural NOS (nNOS). (3)
Cardiomyoctes express both iNOS and eNOS. (4, 38) The two isozymes differ, in that
eNOS is constitutively active whereas iNOS is not.

The role of NO in the classical form

of P C is somewhat controversial. Some studies have shown that NO plays a major role
in classic PC (25). Others suggest that endogenous NO does not induce early
cardioprotection (CP) (24, 39). In contrast, the role of NO in initiating and mediating the
SWOP is more clearly defined. Several studies demonstrated that inhibiting NOS with Nnitro-L-arginine methyl ester (L-NAME) blocked delayed protection against myocardial
stunning and infarction (7, 40). Bolli et al. 1998, further purposed that NO played a
bifunctional role in P C . They suggested that eNOS initiated the protective response in
early PC and iNOS mediated the SWOP (6). Subsequent measurements of NOS activity
showed that NO production followed a biphasic pattern which confirmed the
aforementioned hypothesis (47). Furthermore, Kukreja et al. showed that the non-toxic

-
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endotoxin monophosphoryl lipid A (MLA), a pharmaceutical trigger of the SWOP, failed
to protect in iNOS knockout mice. This study was the first to demonstrate the importance
of iNOS in delayed pharmacological preconditioning using iNOS knockout mice (45).

cGMP Activated Protein Kinase (PKG)
PKG is a serinelthreonine kinase that is activated by cGMP. PKG consists of two
types.

Type 1 is a soluble homodimer and it is found mostly in smooth muscle,

endothelial cells, and platelets of .the cardiovascular system.

PKG type 1 has two

isoforms a and p. The a form is more sensitive to activation by cGMP. Abundant
amounts of PKGla are found in the human aorta, heart, kidneys, and adrenal glands.
PKGlP is found in the human uterus (42). Type I1 is membrane bound and it is
predominantly found in the intestine, kidney, and brain.
PKG mediates vascular smooth muscle tone and growth.

It also governs

endothelial cell mobility and permeability and platelet function (5). PKG is thought to
mediate these processes through regulation of cytoplamsic ~

a levels.
+ ~

It has been

demonstrated that homozygous deletion of the PKG 1 gene abolished the NOIcGMP
relaxation of smooth muscle.

The knockout mice also had vascular and intestinal

dysfunction and died at an early age (32). PKG I1 knockout mice lived normal lifespans
but were affected by increased longitudinal bone growth, increased intestinal chloride
secretion, and altered renin secretion (31). The PKG pathway has been shown to be
integral in preventing apoptosis in neural cells (41).

Interestingly, the adenoviral

overexpression of PKG was found to have an antiproliferative and pro-apoptotic effect in
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vascular smooth muscle (9) however, the effect of apoptosis in cardiomyocytes remains

unclear.
PKG also plays an important role in the cardiovascular system. Initially, PKG
was found to phosphorylate and subsequently activate the KATPchannel in isolated rat
cardiomyocytes (12, 18). Also, it was shown that NO induced cardioprotection through
the opening of mitoKATPchannels was PKG dependent (46). PKG is also known to be
integral in both bradykinin and sildenafil mediated cardioprotection (26, 28).

ATP sensitive Potassium Channels
The KATPchannel is a potassium channel that is inhibited by physiological levels
of ATP (49). Cardiomyocytes have both sarcolemmal and mitochondrial KATpchannels
( m i t o K ~ (50).
~ ~ ) Both types are composed of an inward rectifying channel (Kir) and a
sulfonyl urea binding protein (S,,).

These channels differ however in their response to

various pharmacological agents. The mitoKATPchannel is more sensitive to the blocker,
5-hydroxydecanoate (5-HD) and the opener of the channel diazoxide (13). It has been
shown that the opening of the mitoKATPchannel is mostly responsible for the P C
response (20,36).

KATPas end effectors
In the late nineties some studies suggested that the opening of KATPchannels was
the end effector of P C . Holmuhamedov et. al., 1999 showed that the influx of potassium
into the mitochondrial matrix changed the relative osmotic gradient rendering the
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mitochondria more resistant to ca2+ entry (16). Garlid suggested that the influx of
potassium caused the mitochondria to swell which in turn disrupted the translocation of
adenosine diphosphate (ADP) into the intermembrane space. The subsequent lack of
ADP resulted in the phosphorylation of creatine which in effect created a more efficient
means of energy transfer to other organelles (11). Additionally, the opening of KATP
channels may have an energy sparing effect. Opening of KATPchannels was shown to
decrease glycogen depletion and lactate accumulation (17).Other studies suggested that
the opening of the mitoKATPchannel may function as both trigger and mediator. The
research in this area focused on timing of 5-HD infusion. It has been shown that blocking
the mitoKATPchannel during the initial period of ischemia blocked cardioprotection,
however the majority of the studies have found that administration of 5-HD during the
second longer phase of ischemia attenuated cardioprotection, suggesting the role of
mitoKATPchannels as a mediator of cardioprotection (30, 43). It was then shown by
several investigators that the opening of the mitoKATPchannel resulted in the production
reactive oxygen species (ROS).

ROS then serves as second messenger activating

signaling molecules including PKC and p38 MAP kinase leading to the activation of the
end effector (27). Furthermore, it was found that the PC effect elicited by bradykinin,
opioids, and acetylcholine was dependent on the opening of KATPchannels and the
subsequent generation of ROS (27,48).

Necrosis & Apoptosis
The two most common types of cell death that occur as a result of ischemic injury
are necrosis and apoptosis (19). Cell death is most clearly defined as the point at which
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the cell becomes unable to recover its normal function and morphology. Necrosis and
apoptosis differ greatly in their inherent cause and resulting effect. Necrosis occurs as a
result of exogenous injury and results in cell swelling and lysis. Morphologically, it is
characterized by the disruption of cellular organelles, accumulation of ribosomes on the
nucleus, and irregular aggregation of chromatin within the nucleus. Apoptosis differs
from necrosis because it is programmed cell death and it results in cell condensation and
cell fragmentation. Apoptosis is characterized by crescent shaped chromatin, apoptotic
bodies, and DNA fragmentation.
The intracellular pathway leading to apoptosis involves the releases of cytochrome
c from the mitochondria. Cytochrome c activates a caspase cascade which leads to
protein cleavage and DNA fragmentation eventually causing cell death. Bax promotes
apoptosis by facilitating the release of cytochrome c from the mitochondria. Conversely,
Bcl-2 is an anti-apoptotic protein which deactivates BAX, subsequently preventing the
release of cytochrome c and activation of the caspase cascade.

Goals of the Study
The goal of the current study was to establish the role of PKG in P C against both
necrosis and apoptosis. The second objective of the study was to determine if the direct
overexperssion of PKG-la induced protection against necrosis and apoptosis. The role of
PKG in P C was investigated by using the PKG inhibitor KT5832. Given that PKG is
known to participate in several forms of pharmacologically induced cardioprotection (26,
28), we assumed that KT5832 would abrogate the protective effect of IPC. Furthermore,
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we investigated the role of PKG in protection against ischemia / reperfusion injury
through the adenoviral overexpression of PKG- 1a.

CHAPTER 2
Methods & Materials
Isolation of Ventricular Myocytes
Adult Wistar rats were purchased from Harlan (Indianapolis, IN). Ventricular
myocytes were isolated using a modified enzymatic technique (34, 44). In short, the rat
was anesthetized with pentobarbital sodium (100mg/kg, i.p.) and the heart was quickly
removed from the chest.

The aortic opening was cannulated onto the Langendorff

perfusion system within three min. and the heart was retrogradely perfused (37°C) for
approximately 15 min with ca2+free bicarbonate based buffer containing (m mom): 120
NaC1, 5.4 KC1, 1.2 MgS04, 1.2 NaH2P04, 5.6 glucose, 20 NaHC03, 10 BDM (2,3butanedione monoxime) and 5 taurine, which was continuously gassed with 95% 0 2

+

5%C02. The heart was then subjected to enzymatic digestion by adding collagenase type
I1 (Worthington, OSmgIml) and protease type XIV (0.02 mglml) to the perfusion buffer
for 45 min. The heart was then removed from the Langendorff system and the atrium was
separated from the ventricle. The digested ventricular tissue was minced into smaller
fragments and gently aspirated with a transfer pipette to facilitate cell dissociation. The
cell pellet was resuspended in a three step ca2+restoration procedure (i.e. 125, 250, 500
pmoVL Ca+2). The freshly isolated cardiomyocytes were then suspended in Medium 199
containing 2mmoVL L-carnitine, 5mmoVL creatine, 5mmoVL Taurine, 5mmolL glucose,

.1ymol/L insulin, 10% fetal bovine serum (FBS) and 0.1% penicillin-streptomycin (PS)

for 18 hrs. The cells were then plated onto 35mm cell culture dishes, which were precoated with 20 pg/ml mouse laminin in PBS

+ 1% PS for 1 hour.

The cardiomyocytes

were cultured in the presence of 5% C 0 2 for at least 18 hrs in a humidified incubator at
37"C, which allowed myocytes to attach to the dish surface prior to experimental
protocol.

Experimental Protocol
The detailed experimental protocol is diagrammed in (Fig. 3).

The cultured

myocytes were incubated under 37°C and 5% C 0 2 for one hour with or without the PKG
inhibitor, KT 5832 (2pmolIL) by adding the drug directly to the cell medium. In an
alternate experimental group, cells were infected with a PKG l a adenoviral construct 24
hrs prior to SI and RO at a concentration of 1x10~particles per cell (Fig. 4). Ischemic
preconditioning was induced by replacing the cell medium with an "ischemic buffer"
which contained (in mmoVL): 118 NaC1, 24 NaHC03, 1.0 NaH2P04,2.5 CaC12-2H20,1.2
MgC12, 20 sodium lactate, 16 KC1, 10 2-deoxyglucose (pH adjusted to 6.2) similar to a
previously published method(34).

Afterwards, cells were incubated under hypoxic

conditions at 37°C by adjusting the tri-gas incubator to 1% 0

2

and 5% C 0 2 for 30 min.

IPC was concluded by replacing the ischemic buffer with normal medium under
normoxic conditions for 30 min. Following P C cells were subjected to longer periods of
ischemia for 90 min. and RO which lasted either 120 min (for assessing necrosis) or 18
hours (for detecting apoptosis).

Ischemia

Control

Reoxygenation

I

Western

IPC
Buffero;

Apoptosis

&
Necrosis

118 NaCl

Rakhit et al. Am J Physiol 278:H1211-H1217,2000)

Figure 3: Experimental Protocol showing times of administration of ischemic
preconditioning (IPC), PKG blocker KT 5832 and the composition of ischemic
buffer.

Western

Apoptosis

Cells were infected by adenoviral construct of PKGla (1x1 O4
particlelcell)

Figure 4: Experimental protocol showing the time of administration of the
adenoviral construct of PKG la (AD-PKG la).
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Evaluation of Cell Viability
Cell viability was assessed by trypan blue exclusion assay. At the end of protocol,
40 p L of 0.4% trypan blue (Sigma-Adrich) was added into the culture dish. After -5min
of equilibration, stained cells were counted under the microscope.

TUNEL Staining and Measurement of Mitochondria1 Membrane Potential.
Apoptosis was analyzed by terminal deoxynucleotidyl transferase mediated nick
labeling (TUNEL) staining, using a kit purchased from BD Biosciences, which detects
nuclear fragmentation by a fluorescence assay. In brief, after SI and 18 hrs of RO, the
cells were fixed in two chambered slides by 4% formaldehyde1PBS at 4°C for 25 min
and subjected to TUNEL assay according to the manufacturer's protocol. The slides were
then counter-stained with Vectashield mounting medium with DAPI (4'6-diamidino-2phenylindole, a DNA inatercalating dye for visualizing nuclei in fixed cells, catalogue #

H- 1200, Vector Laboratories).
Western Blots for BAX and Bcl-2
Total soluble protein was extracted from the cells with Reporter Lysis Buffer
(Promega). The homogenate was centrifuged at 10,000 g for 5 min under 4°C and the
supernatant was recovered. 25 pg of protein from each sample was separated by 12%
acylamide gels and transferred to a nitrocellulose membrane, and then blocked with 5%
non-fat dry milk in TBST (10 mmol/L Tris-HCL, ph 7.4, 100 mmol NaC1, and . l %
Tween 20) for 60 min. The membrane was then incubated with rabbit polyclonal primary
antibody at a dilution of 1:1000 for BAX and Bcl-2 (Santa Cruz) for 120 min before
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being washed and incubated with anti-rabbit horseradish peroxidase-conjugated
secondary antibody (1:2000, Amersham) for 1 hr. The blot was developed using a
chemiluminescent system. The optical density for each blot band was scanned and
quantified using a densitometric system (Bioquant 98).

Data Analysis and Statistics
Data were presented as means

+ SEM.

The differences between control and

experimental groups were analyzed with one-way ANOVA followed by StudentNewman-Keuls post hoc tests. Pc0.05 was considered statistically significant.

CHAPTER 3
Results
Effect of Ischemic Preconditioning on Cardiomyocyte Necrosis
The method for cell preparations yielded at least 70% of the myocytes with rod
shaped morphology which was similar to previously reported studies(34, 44). Figure 5
shows a typical preparation of isolated adult rat cardiomyocytes used in the present study.
IPC resulted in the decrease in trypan blue positive cardiomyocytes, i.e. from 22.3+2.40%
of total counted cells in the SI group to 11.2+0.83% in the P C group. Pretreatment with
the PKG inhibitor KT5832 abrogated IPC protection and resulted in similar amounts of
trypan blue positive cells between IPC versus SI groups, i.e. 25.32+2.73% and
26.65&0.61%respectively.(Fig. 6,7)

Effect of Ischemic Preconditioning on Cardiomyocytes Apoptosis
As shown in (Fig. 8,9) apoptotic cell death became evident following 90 min of
ischemia and 18 hrs of RO, i.e. 29.91*3.54% of total counted myocytes. The number of

TUNEL positive cells were reduced to 16.42+0.76% following P C . Pretreatment of cells
with KT5832 did not block IPC induced protection against apoptosis. In groups

Figure 5: Representative image of freshly isolated rat cardiomyocytes.

Figure 6: Effect of ischemic preconditioning on necrosis. Bar diagram showing
quantitative data from four separate experiments.

KT-

IPC
-

.

Figure 7: Representative images of cardiomyocytes stained with trypan blue. A)
Myocytes subjected to 90 rnin of SI and 120 min of RO alone. Cell necrosis is clearly
evident by the increased number of trypan blue-positive myocytes. B) Myocytes
subjected to IPC prior to SI and RO. Showing less trypan blue-positive myocytes
compared with untreated myocytes in A). C) Myocytes pretreated with KT 5832
prior to SI and RO. D) Myocytes pretreated with KT 5832 prior to IPC. Note that
there is no significant difference between C) and D).

Figure 8: Effect of ischemic preconditioning on apoptosis. Bar diagram showing
quantitative data from four separate experiments.

KT-

Figure 9: Representative images of cardiomyoctes subjected to TUNEL assay. A)
Myocytes subjected to 90 min of SI and 120 min of RO alone. Apoptosis is clearly
evident by the increased number of TUNEL positive nuclei indicated by the
presence of the fluorescent green stain. B) Myocytes subjected to IPC prior to SI
and RO. Note that there are less TUNEL positive myocytes compared to SI alone.
C) Myocytes pretreated with KT 5832 prior to SI and RO. D) Myocytes pretreated
with KT5832 prior to IPC. Note that there are significantly less TUNEL positive
cells in both groups subjected to IPC compared to cells subjected to SI and RO
alone.

pretreated with KT 5832, P C resulted in the decrease of TUNEL positive
cardiomyocytes, i.e. from 26.93+2.03% in the SI group to 11.22+1.33% in the IPC group.
We also examined the effect of IPC on the expression of the anti-apoptotic protein
Bcl-2 and the pro-apoptotic protein Bax in cardiomyocytes. As shown in (Fig. IOA) IPC
enhanced the expression of Bcl-2. The induction of Bcl-2 occurred after 90 min of SI and
120 of RO. The Bcl-2 / Bax ratio was partially attenuated by the pretreatment of cells
with KT 5832 (Fig. IOB).

Effect of PKG overexpression on Cardiomyocyte Necrosis & Apoptosis
To further evaluate the role of PKG in cardioprotection, we used the adenoviral
construct of PKG-la to overexpress the protein in the cardiomyoctes: As shown in (Fig.
1lA), adenoviral construct PKG-la increased the levels of the PKG-la as compared to
control. The overexpression of PKG-la resulted in the decrease of trypan blue positive
cardiomyocytes, i.e. from 36.07+ 3.12% of total counted myocytes in the untreated
control group to 20.67+1.00% in cells infected with the PKG-la construct (Fig. 11 B,C).
Similarly, the overexpression of PKG-la also reduced the number of TUNEL positive
myocytes from 15.30+ 0.70% in the untreated control to 6.30+ 1.10% in the group
infected with the adenovirus (Fig. 12).

0.-

-

Conirol

IPC IPC KT+

Figure 10: Effect of IPC on the expression of Bcl-2 & Bax. A) Representative gel
showing Bcl-2, Bax, and fJ actin expression following IPC and KT 5832
administration. B) Bar diagram showing the quantitative change in Bcl-2Bax ratio.

C.

Control

PKG la-

I
,

nu-rnuIU

n=3 p4.01

Figure 11: Overexpression of PKG la protects myocytes against necrosis. A) A
representative gel showing PKG la in myocytes infected with adenovirus. B) Bar
diagrams showing cell viability determined by trypan blue staining.
C)
Representative picture of trypan blue staining. Note that the blue stained cells
represent myocytes affected by necrosis.

Figure 12: Effect of the overexpresion of PKG la on apoptosis. A) Bar diagram
shown quantitative data that assessed cell viability through TUNEL staining. B,C)
non infected control C,D) Adenoviral PKG l a infected cells. B,D) TUNEL positive
myocyte nuclei (stained in green fluorescent color). C,E) Total nuclei (4,6diamidino-2-phenylindole staining). A significant number of myocytes underwent
apoptosis whereas infection with adenovirus reduced TUNEL positive nuclei.

Chapter 4

Discussion

Brief periods of ischemia have been found to elicit physiological changes in the
heart that protect the myocardium against longer subsequent periods of ischemia. The
complete cellular pathway that confers this type of protection has been the subject of
many studies, but the specific sequence of events and the end effector is still unknown.
Insights into the pathway that lead to CP have profound clinical implications. Mainly IPC
is of interest because it may lead to new pharmacological treatments for heart disease.
The current investigation is relevant in that it clarifies the role of PKG within the IPC
cascade.
It has been shown through patch clamp studies on isolated myocytes that the NOcGMP-PKG pathway contributes to the phosphorylation and activation of KATPchannels
(14). The opening of the mitoKATPchannels has been shown to trigger CP through the

generation of ROS (25, 30). Other studies have shown that pharmacological agents such
as sildenafil and bradykinin may also induce CP through the NO-cGMP-PKG-mitoKATp
pathway.

28
Kukreja and colleagues have shown that Sildenafil induced a powerful
cardioprotective effect in vivo(26). Sildenafil preconditioned mice cardiac myocytes
against apoptosis and necrosis through a NO dependent signaling pathway (10). These
results suggested that the increased concentration of cGMP is integral in the PC cascade.
PKG is known to be a cellular target of cGMP in the putative PC cascade. Sildenafil
inhibits the degradation of cGMP, subsequently increasing its concentration allowing for
a more robust activation of PKG.
The primary objective of this study was to determine the role of PKG in IPC
induced protection against both necrosis and apoptosis in the isolated cardiomyocyte
model. A second goal was to show that the direct overexpression of PKG-la induced
protection against necrosis and apoptosis in cardiomyocytes. Our experimental model
examined the effect of P C on the isolated myocyte which allowed for conjecture
regarding the resulting endogenous processes which is untainted by other cell types, their
products, or any other hemodynamic factors. Evaluation of these results, however should
take into account the possibility that the isolation procedure, which induces physical and
environmental stress, may itself serve as a PC stimulus (33).

IPC Induced Protection against Necrosis
Trypan blue exclusion assay measured the osmotic fragility of individual cells.
Necrosis involves the swelling and lysis of cells allowing for trypan blue uptake. Similar
to other studies, when subjecting the cells to P C prior to a longer period of ischemia, cell
viability was significantly increased (39). Specifically, IPC decreased the number of
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trypan blue positive cells by 5 1% relative to the untreated SI group. The results confirm
the ability of myocytes to endogenously protect themselves through IPC.
Previous studies have shown that various PKG modulators influence ROS
generation (29, 46). Oldenberg and colleagues demonstrated that the NO-cGMP-PKGmitoKATPpathway triggered by bradykinin lead to CP, similarly Xu and colleagues have
shown this pathway to be triggered by an exogenous supply of NO supplied by S-nitrosoN-acetylpenicllamine (SNAP). These experiments suggested that PKG is involved in the
production of ROS which were also associated with cardioprotection. The experiments
however only provided circumstantial evidence that PKG is responsible for
cardioprotection. In the present study, we established a direct link between IPC, PKG,
and CP against necrosis. We have shown that pretreatment with the PKG inhibitor
KT5832 abrogated PC's protective effect against necrosis suggesting an essential role of
PKG in CP.

IPC induced protection against Apoptosis
In addition to necrosis, apoptosis is known to contribute to cell death in ischemic
injury (2,15).

Apoptosis is programmed cell death that results in a variety of

morphological and functional changes. A distinguishing feature of apoptosis is the
fragmentation of nuclear DNA. The TUNEL assay attaches fluorescein-dUTP to
fragmented DNA pieces allowing for the quantitative analysis of cells affected by
apoptosis.
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There are conflicting reports as to PKG's role in apoptosis. The PKG pathway has
been shown to play an essential role in preventing apoptosis in neural cells (41). A
previous report by Shimojo et. a1 revealed that the NO-cGMP pathway induced apoptosis
in neonatal cardiomyocytes (37). A subsequent study by Akao and colleagues asserted
that the opening of mitoKATPchannels inhibited apoptosis induced by oxidative stress (1).
These results appear to be incongruent given that the NO-cGMP-PKG pathway triggers
the opening of mitokATPchannels. The contrasting results may be explained by the dose
of SNAP (0.1rnM) used by Shimojo and colleagues. The cardioprotective effect against
necrosis was shown to be elicited by 20 pM dose of SNAP (46), which suggests that the
NO signaling pathway can have both deleterious and protective effects. However, the
therapeutic capacity is highly dependent on the dose of NO and cell type (35).
The current study has shown that P C significantly decreased the number of
TUNEL positive cells as compared to cells subjected to SI alone which indicates that
myocytes posses the endogenous ability to protect themselves against apoptosis. P C ' s
protective effect against apoptosis was not diminished by KT5832 suggesting that PKG
was not solely responsible for P C induced protection against apoptosis. The antiapoptotic protein, Bcl-2 was up regulated during IPC while the pro apoptotic Bax protein
level was not significantly changed. Administration of KT 5832 diminished the IPC
induced increase of Bcl-2. PKG was involved in the IPC induced alteration of the Bax
/Bcl-2 ratio which favored anti-apoptosis. Although protein analysis seems to implicate
PKG in P C mediated protection against apoptosis, the induced change of the Bax I Bcl-2
ratio may not have been strong enough to protect the cells against apoptosis eighteen
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hours post ischemia. This hypothesis may explain the inablility of KT 5832 to abrogate
IPC induced protection against apoptosis. In contrast, the overexpression of PKG-la by
adenoviral gene transfer reduced necrosis as well as apoptosis as demonstrated by
significantly less trypan blue and TUNEL positive stained cells.

Conclusion
Both necrosis and apoptosis proceed through vastly different cellular signaling
pathways, therefore it might be logical to conclude that the pathways governing IPC
against each form of cell death may also follow vastly different pathways. In the present
study, we have shown that PKG was involved in IPC against necrosis but not apoptosis.
The overexpression of PKG protects myocytes against both necrosis and apoptosis. Our
results further suggest that PKG can protect against apoptosis by altering the Bcl-2Bax
ratio. Further studies are needed to understand the downstream signaling pathway by
which PKG exerts protective effects against necrosis and apoptosis in the myocytes.
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